108 related articles for article (PubMed ID: 31887372)
1. The small quinolone derived compound HT61 enhances the effect of tobramycin against Pseudomonas aeruginosa in vitro and in vivo.
Amison RT; Faure ME; O'Shaughnessy BG; Bruce KD; Hu Y; Coates A; Page CP
Pulm Pharmacol Ther; 2020 Apr; 61():101884. PubMed ID: 31887372
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies.
Hu Y; Coates AR
J Antimicrob Chemother; 2013 Feb; 68(2):374-84. PubMed ID: 23042813
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
McCaughey G; McKevitt M; Elborn JS; Tunney MM
J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
[TBL] [Abstract][Full Text] [Related]
4. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
Feizi S; Cooksley CM; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S
Pathology; 2022 Jun; 54(4):453-459. PubMed ID: 34844745
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal Effect of Tomatidine-Tobramycin Combination against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Is Enhanced by Interspecific Small-Molecule Interactions.
Boulanger S; Mitchell G; Bouarab K; Marsault É; Cantin A; Frost EH; Déziel E; Malouin F
Antimicrob Agents Chemother; 2015 Dec; 59(12):7458-64. PubMed ID: 26392496
[TBL] [Abstract][Full Text] [Related]
6. In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media.
Thellin O; Zorzi W; Jolois O; Elmoualij B; Duysens G; Cahay B; Streel B; Charif M; Bastin R; Heinen E; Quatresooz P
Int J Antimicrob Agents; 2015 Jul; 46(1):33-8. PubMed ID: 25963337
[TBL] [Abstract][Full Text] [Related]
7. Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas.
Chan EL; Zabransky RJ
Diagn Microbiol Infect Dis; 1987 Feb; 6(2):157-64. PubMed ID: 3102156
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
Chalkley LJ; Koornhof HJ
Antimicrob Agents Chemother; 1985 Aug; 28(2):331-42. PubMed ID: 2939797
[TBL] [Abstract][Full Text] [Related]
9. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
Nagant C; Tré-Hardy M; El-Ouaaliti M; Savage P; Devleeschouwer M; Dehaye JP
Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations.
Díez-Aguilar M; Morosini MI; Tedim AP; Rodríguez I; Aktaş Z; Cantón R
Antimicrob Agents Chemother; 2015 Oct; 59(10):6039-45. PubMed ID: 26195514
[TBL] [Abstract][Full Text] [Related]
11. Biofilm Antimicrobial Susceptibility Increases With Antimicrobial Exposure Time.
Castaneda P; McLaren A; Tavaziva G; Overstreet D
Clin Orthop Relat Res; 2016 Jul; 474(7):1659-64. PubMed ID: 26797908
[TBL] [Abstract][Full Text] [Related]
12. The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential.
Maiden MM; Zachos MP; Waters CM
J Antimicrob Chemother; 2019 Apr; 74(4):894-906. PubMed ID: 30624737
[TBL] [Abstract][Full Text] [Related]
13. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
14. Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.
Comber KR; Basker MJ; Osborne CD; Sutherland R
Antimicrob Agents Chemother; 1977 Jun; 11(6):956-64. PubMed ID: 406837
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
Angehrn P
Eur J Clin Microbiol; 1983 Oct; 2(5):489-95. PubMed ID: 6315424
[TBL] [Abstract][Full Text] [Related]
17. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.
den Hollander JG; Horrevorts AM; van Goor ML; Verbrugh HA; Mouton JW
Antimicrob Agents Chemother; 1997 Jan; 41(1):95-100. PubMed ID: 8980762
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
McGhee P; Clark C; Credito K; Beachel L; Pankuch GA; Appelbaum PC; Kosowska-Shick K
Antimicrob Agents Chemother; 2011 May; 55(5):2417-9. PubMed ID: 21343445
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
[No Abstract] [Full Text] [Related]
20. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.
Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
Drugs; 1976; 12(3):166-200. PubMed ID: 789045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
